You are not logged in.
Login to update your contact information or edit your email preferences, or Register to create an account.
In 1978 the FDA
proposed to regulate antibacterial soaps and allow on the market only those it determined
were safe and effective. However, the agency created a loophole for most of the
chemicals: the FDA stated there was not enough data to say the chemicals were
safe or effective, yet allowed them to stay on the market until the agency
finalized its proposal.
Nearly four decades
later, the FDA has still never made a final determination, but the use of
triclosan, a known hormone disruptor that may lead to antibiotic resistance,
has mushroomed—it’s now found in an estimated 75% of antibacterial liquid soaps
and body washes sold in the US, as well as in mouthwash, toothpaste, and toys.
Bowing to pressure,
the FDA’s researchers finally plan to deliver a review this year on the
effectiveness and safety of triclosan and a close relative, triclocarban, used
in bar soaps. The agency plans to take action by 2016, yet this review
is nowhere listed in the FDA’s Strategic Priorities document for FY 2014–2018. Demand
that they stick to their stated 2016 deadline, and suggest they issue a draft
proposal on triclosan by 2015 to give the public time to review and comment.
personalize your message if you have the time!)
Dear [Decision Maker],
Sincerely,[Your Name] [Your Address] [City, State ZIP]